66 patents
Page 2 of 4
Utility
Human Plasma Kallikrein Inhibitors
23 Feb 23
Pravin L. Kotian, Yarlagadda S. Babu, Minwan Wu, Venkat R. Chintareddy, V. Satish Kumar, Weihe Zhang
Filed: 9 Nov 21
Utility
Indole compounds and analogues thereof
24 Jan 23
Pravin L. Kotian, Yarlagadda S. Babu, Weihe Zhang, Lakshminarayana Vogeti, Minwan Wu, Venkat R. Chintareddy, Krishnan Raman
Filed: 26 Aug 20
Utility
Substituted Benzofuran, Benzopyrrole, Benzothiophene, and Structurally Related Complement Inhibitors
10 Nov 22
Pravin L. Kotian, Yarlagadda S. Babu, Weihe Zhang, Peng-Cheng Lu, Minwan Wu, Wei Lv, Trung Xuan Nguyen, Zhao Dang, Venkat R. Chintareddy, V. Satish Kumar, Krishnan Raman
Filed: 5 Feb 21
Utility
Imidazole-containing Inhibitors of ALK2 Kinase
20 Oct 22
Pravin L. Kotian, Yarlagadda S. Babu, V. Satish Kumar, Weihe Zhang, Peng-Cheng Lu, Krishnan Raman
Filed: 14 Jun 18
Utility
Antiviral treatments
11 Oct 22
The invention provides unit dosage forms, kits, and methods useful for treating viral infections.
Yarlagadda S Babu, Pooran Chand, Shanta Bantia, Shane Arnold, John Michael Kilpatrick
Filed: 6 Aug 19
Utility
Process-scale Synthesis of a Plasma Kallikrein Inhibitor
15 Sep 22
Yahya El-Kattan, Yarlagadda S. Babu
Filed: 5 Aug 20
Utility
Dosing Regimens for Oral Complement Factor D Inhibitors
18 Aug 22
Disclosed are compounds and pharmaceutically acceptable salts and prodrugs thereof, which are inhibitors of the complement system.
Yarlagadda S. Babu, William P. Sheridan
Filed: 29 Jul 20
Utility
Crystalline Salts of a Plasma Kallikrein Inhibitor
30 Jun 22
Yahya El-Kattan, Yarlagadda S. Babu
Filed: 2 Sep 21
Utility
Plasma Kallikrein Inhibitors and Methods of Use Thereof In Ocular Disorders
26 May 22
This disclosure is generally in the field of ophthalmic therapies, and more particularly to the treatment of various ocular diseases and conditions by non-surgical administration to the eye of a subject of a drug composition described herein containing a plasma kallikrein inhibitor.
Yarlagadda Babu, Viral Kansara, Rick McElheny
Filed: 8 Apr 20
Utility
Human Plasma Kallikrein Inhibitors
31 Mar 22
Pravin L. Kotian, Yarlagadda S. Babu, V. Satish Kumar, Weihe Zhang, Lakshminarayana Vogeti
Filed: 13 Jul 21
Utility
Methods of Treating Hematologic Cancers
10 Feb 22
The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits.
Shanta BANTIA, Philip BREITFELD, Yarlagadda S. BABU
Filed: 4 Aug 21
Utility
Antiviral Treatments
10 Feb 22
The invention provides unit dosage forms, kits, and methods useful for treating viral infections.
Yarlagadda S. BABU, Pooran Chand, Shanta Bantia, Shane Arnold, John Michael Kilpatrick
Filed: 21 Jul 21
Utility
Methods and Compositions for Inhibition of Polymerase
10 Feb 22
The present invention is directed to methods and compositions for inhibition of viral nucleic acid polymerases, such as RNA and DNA polymerases, and methods and compositions that are useful for treating viral infections in subjects.
Shanta Bantia, Pravin L. Kotian, Yarlagadda S. Babu
Filed: 21 Oct 21
Utility
Human plasma kallikrein inhibitors
25 Jan 22
Pravin L. Kotian, Yarlagadda S. Babu, Minwan Wu, Venkat R. Chintareddy, V. Satish Kumar, Weihe Zhang
Filed: 10 Apr 20
Utility
Human plasma kallikrein inhibitors
21 Dec 21
Pravin L. Kotian, Yarlagadda S. Babu, Minwan Wu, Venkat R. Chintareddy, V. Satish Kumar, Weihe Zhang
Filed: 24 Mar 20
Utility
Human plasma kallikrein inhibitors
7 Dec 21
Pravin L. Kotian, Yarlagadda S. Babu, Minwan Wu, Venkat R. Chintareddy, V. Satish Kumar, Weihe Zhang
Filed: 24 Mar 20
Utility
Methods and compositions for inhibition of polymerase
16 Nov 21
The present invention is directed to methods and compositions for inhibition of viral nucleic acid polymerases, such as RNA and DNA polymerases, and methods and compositions that are useful for treating viral infections in subjects.
Shanta Bantia, Pravin L. Kotian, Yarlagadda S. Babu
Filed: 16 Aug 19
Utility
Crystalline salts of a plasma kallikrein inhibitor
14 Sep 21
Yahya El-Kattan, Yarlagadda S. Babu
Filed: 6 Feb 20
Utility
Methods of treating hematologic cancers
7 Sep 21
The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits.
Shanta Bantia, Philip Breitfeld, Yarlagadda S Babu
Filed: 1 May 19
Utility
Benzopyrazole Compounds and Analogues Thereof
26 Aug 21
Pravin L. Kotian, Yarlagadda S. Babu, Weihe Zhang, Lakshminarayana Vogeti, Minwan Wu, Venkat R. Chintareddy, Krishnan Raman
Filed: 26 Aug 20